MC Services: experts in corporate communication and investor relations
120
page-template,page-template-full_width,page-template-full_width-php,page,page-id-120,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

The highest standards. The happiest customers. What our clients have to say about us.

I have worked with MC Services since 2012. What sets them apart from other agencies is their unprecedented customer service, how well they understand our business and consequently how impactful their IR and PR strategies and activities are.

Christian Pangratz, CEO, Atriva Therapeutics

For us as a NASDAQ listed company, creating awareness is of tremendous importance. MC Services is an ideal partner for providing strategic IR insight, making media and investor connections and supporting us at events to increase our company’s visibility among pan-European investors. We value their professional perspective and comprehensive know-how, as well as their extensive network.

Dror Ben-Asher, CEO, RedHill Biopharma

We have been working with MC Services for over two years in the areas of Investor Relations for Europe and Public Relations in Germany. The MC Services team did a great job in supporting us in our latest financing activities and identified several new long-term investors across Europe. They also have successfully secured high quality German media coverage for our Company on an ongoing basis, including extensive coverage of the German market launch and European roll-out of Xadago, our first product on the market. I very much appreciate the dedicated support and professionalism of the entire team. They are truly a pleasure to work with.

Stefan Weber, CEO, Newron Pharmaceuticals S.p.A

In the 8 years I have worked with MC Services across several organisations, what sets them apart is their ability to routinely come up with new strategic ideas to support our company goals, many of which I had not considered until they were proposed. These have consistently had a beneficial impact and exceeded my expectations. MCS have had a positive effect on many aspects of our business in the core areas of PR and IR but also beyond. Their impact is multi-facetted; they have become a member of the family who is invested in our corporate mission and building the company.

Andrew Mackie, Chief Business Officer, Imcyse SA

Over the many years MorphoSys has worked with MC Services, we established a trusted and collaborative partnership. As a client, I value the team’s deep knowledge of the German and international media landscape, providing valuable insights in how we engage with reporters. You will always get an honest and thoughtful recommendation from their team.

Thomas Biegi, Vice President Corporate Communications, MorphoSys AG

MC Services with their teams in Munich and Düsseldorf, as well as outposts in the UK and US, provide excellent support to their clients, their journalist partners and members of the financial community. All team members are highly professional, responsive to client needs and create great opportunities for dialogue and sharing information.

Dr. David Ebsworth, Non-Executive Chairperson of the Board, Verona Pharma plc

MC Services has a profound understanding of the technology, product and communication opportunities in biotechnology. The high quality end products they deliver bring clarity into the complexity of biology and balance sheets

Dr. Werner Lanthaler, CEO, Evotec AG

The team at MC Services brings a deep understanding of media and investor relations in the life sciences. They work with precision and professionalism, and our interactions are always a pleasure.

Dave Marver, CEO, ONWARD Medical N.V.

The MC Services team has been a key partner to further my organization's goal to increase awareness amongst our most important target audiences. We are a small Series B startup, and their reach has been invaluable to help reach all of our stakeholders - physicians, industry partners, investment community, and patients alike.

Jeff Martin, Vice President of Global Marketing, Volta Medical

SELECT CLIENTS – PAST AND PRESENT